GxP Best Practices Part 2: Early Stage Tips for Data Integrity
September 23, 2024
In Teresa Gorecki’s second session of Executive-level GxP training, the two reviewed Regulatory
In Teresa Gorecki’s second session of Executive-level GxP training, the two reviewed Regulatory
The FDA and other global regulators rely on data reviews during inspections to determine whether a
We are excited to announce that our CEO, Jack Garvey, has been selected
The FDA has long taken a risk-based approach to manufacturer GMP compliance expectations
Being able to present data that the FDA believes it can trust is
Data drives the pharmaceutical and medical device industries. It informs the manufacture and
© 2009-2025 Compliance Architects Holdings LLC – used by permission. All copyrights, trademarks and other intellectual property are the property of Compliance Architects Holdings LLC and are used by permission.
